JDD Multimedia

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Love2

The Journal of Drugs in Dermatology (JDD)  is proud to present an essential education program on the topic of guidelines for safely reopening dermatology practices during the COVID-19 pandemic, lead by Dr. Jeffrey S. Dover, Director of SkinCare Physicians in Chestnut Hill, Massachusetts and a panel of dermatology thought leaders.

This video series was produced by the Journal of Drugs in Dermatology and supported in part by Alastin Skincare, Endo Aesthetics. Ortho Dermatologics, and Sciton.

Supported in part by

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Play Video

Featuring Dr. Jeffrey S. Dover

Discussion Topics

  • Medical Office Preparedness
  • Managing the Office Environment
  • General Guidance
  • Cleaning & Disinfecting Practices
  • Practices
  • PPE and Medical Supplies

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Play Video

Featuring Dr. Kavita Mariwalla

Discussion Topics

  • Clinical and Non-Surgical Treatment
  • Related Guidance
  • Treatment room set up
  • Anesthesia and analgesia
  • Injectables

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Play Video

Featuring Dr. Thomas E. Rohrer

Discussion Topics

  • Surgical Treatment
  • Related Guidance
  • Treatment room set up
  • Post-Surgery Follow Up

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Play Video

Featuring Dr. Terrence Keaney

Discussion Topics

  • Non-invasive body contouring
  • Energy-based procedures of the face and neck
  • Skin treatment procedures

Best Practices & Practical Pearls for Safely Reopening Derm Practices

Play Video

Featuring Dr. Nazanin Saedi

Discussion Topics

  • Employee health and training
  • Recognition of symptoms
  • Symptomatic patients and employees
  • Office arrival, check-in and check-out
  • Pre-screening patients

You May Also Like

Journal of Drugs in Dermatology JDD Article about The Gastrointestinal Microbiome and Immune Checkpoint Inhibitors: A Review of Human Interventional Studies Among Melanoma Patients

The Gastrointestinal Microbiome and Immune Checkpoint Inhibitors: A Review of Human Interventional Studies Among Melanoma Patients

| Featured Articles, Latest News, Skin Cancer | No Comments
From the Vault: Fecal transplant may revive immunotherapy responses in melanoma We pulled this February 2024 vault article because it’s been a popular read. It’s a focused review of microbiota‑modulating…
Journal of Drugs in Dermatology JDD Article about GLP-1 Receptor Agonists in Hidradenitis Suppurativa: A Novel Therapeutic Approach for Hidradenitis Suppurativa and Its Comorbidities

GLP-1 Receptor Agonists in Hidradenitis Suppurativa: A Novel Therapeutic Approach for Hidradenitis Suppurativa and Its Comorbidities

| Featured Articles, Hidradenitis Suppurativa, Latest News | No Comments
Metabolic drugs for HS? GLP‑1 receptor agonists show promise beyond weight loss If you haven’t yet, dig into this recent JDD article about GLP-1 receptor agnosists and hidradenitis suppurativa. Hidradenitis…

Isotretinoin Does Not Increase the Risk of Inflammatory Bowel Disease: A TriNetX Retrospective Cohort Analysis

| Acne, Featured Articles, Latest News, Medical Derm | No Comments
Isotretinoin and IBD — large real‑world data offer reassurance In one of our recent JDD articles, a retrospective cohort using the TriNetX network compared acne patients exposed to long‑term, low‑dose…